Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : U.S. Microbics {BUGS} - Environmental Augmentation -- Ignore unavailable to you. Want to Upgrade?

To: MakeAFuss who wrote (171)	11/17/1998 1:50:00 PM
From: GY	Read Replies (1) \| Respond to of 345

Rewards are great for those that wait! I totally agree with the last two posts, especially Frank's "payback is a bitch" Nasdaq NMS here we come!

To: MakeAFuss who wrote (171)	11/20/1998 1:43:00 PM
From: Harry_Behemoth	Read Replies (1) \| Respond to of 345

Friday November 20, 10:55 am Eastern Time Company Press Release SOURCE: U.S. Microbics U.S. Microbics Projects $30 Million in Revenues for Fiscal 1999 CARLSBAD, Calif., Nov. 20 /PRNewswire/ -- U.S. Microbics, Inc. (OTC Bulletin Board: BUGS - news) a marketer of proprietary microbial technologies for environmental cleanup, today said that, for the fiscal year ending September 10, 1999, it anticipates achieving revenues of at least $30 million and net income of $.50 to $1.00 per share. The company will commence filling a $30 million product backlog this December 15, when its new Carlsbad facility begins full operations. These products will be shipped to customers in the commercial, industrial, agricultural and municipal markets. Shipments of BUGS' Bio-Raptor™ system for delivery of these microbial blend products will begin in early 1999, said BUGS president, Robert Brehm. The company has letters of intent for more than 100 Bio-Raptor™ and microbial blend orders, said Brehm, who added that initial revenues from these orders should allow BUGS to qualify for admission to Nasdaq during the first half of next year. Based on market conditions, the company could achieve revenues of up to $100 million by 2002, he said. BUGS' growth will be fueled by licensing the company's proprietary technologies to remediation contractors, petrochemical manufacturers, land fill operators, food processors, governments and other entities in the U.S. and around the world, said Brehm. U.S. Microbics, Inc. creates and markets proprietary microbial technologies that provide natural solutions to a wide array of major environmental problems. Through its acquisition, XyclonyX, the company's technology has been used by former customers including Bechtel Corporation, AT&T, Bank of America, Chevron, IBM, Northrup Grumman Corp., Pacific Bell, Rockwell International, Shell Oil, Standard Oil of California, Texaco, Toyota, the U.S. Department of Energy and other prominent Fortune 500 companies and government agencies. This document contains forward-looking statements. There are certain important factors that could cause results to differ materially from those anticipated by the statements made above. Additional information on these and other factors are included in the company's quarterly reports on Form 10-Q, the company's annual report on Form 10-K ended September 30, 1997, other company reports filed with the S.E.C., and the company's 1997 annual report to shareholders. SOURCE: U.S. Microbics